Attune Tibia issue

It's not the Attune failure catching up, it's the fact depuy dropped the prices of knees to next to nothing to get into accounts or beat stryker pricing which was a new low. Only so far a company can drop the price before rev falls flat and sales reps stop giving a shit like they do now.

 

Care to break that down into segments? Orthopedics is a large segment. Were knee sales down?

 

It's the fact you are a lying shill for a company that has a real issue that hurts and causes pain and suffering. Pathetic.

 

Knee sales down for Depuy this quarter by 4.4%

 

Hey dip shit. We were talking about why pricing is down not how Attune is failing. We all know there is a problem with Attune Baseplates but it's the pricing that's hurting knee sales more then Attune users switching to other companies. Try taking your head out of your ass before typing, and add something relevant to this thread. You sound like a whiny bitch who can't convert a surgeon.

 

Seriously?? And next you're going to say it has hardly anything to do with the exodus of docs switching to another company because of the loosening issue. Grow up hillrod and learn to speak with intelligence rather than your room-temp IQ, trailerpark-rent mouth. Being down 4.5 % in sales quarter comparitively to last year number reflects a huge drop. Zimmer and Stryker knee quarter numbers will be in the 4% to 7% growth category. Get real.

 

Lol. You sound like a douch bag TM that gets passed around like the joint I'm smoking. Seriously.

 

More bad news for Depuy. How long before the hammer drops on the MoM and the courts mandate a settlement. History here at Depuy seems to have a tendancy to repeat itself. I guess will see how things play out for Depuy and the attune knee in the near future. Prediction - BAD times!

It was also interesting to read how J&J blamed some of their poor quarterly performance on the spine division having holes in their product offerings, yet, they sell off prodisc when cervical disc arthroplasty is forecast to grow at roughly 20 percent for a few yrs to come in that category. Meanwhile Depuy Synthes is fairly flat on growth.

http://www.massdevice.com/tampering-concerns-johnson-johnson-lawyers-prompt-judge-trigger-probe/

 

This will result in a recall.

 

After everything said what makes you think now?

 

Bc they finally have the new baseplate to replace the defective ones.

 

That's all been said before, no FDA. Anything else makes you think otherwise? S+ has been out for a little, and FDA has known about it since at least 2015.

 

https://www.levinlaw.com/2017/10/25/uk-analysis-showed-lower-revision-rate-attune-knee-system-fda-data-shows-otherwise

While there is no ready explanation for the discrepancy, it bears mentioning that the NJR report includes the following disclaimer:
"The National Joint Registry produces this report through its contractor, Northgate Public Services (UK) Limited (NPS) using data collected, collated and provided by third parties. As a result, neither NJR or NPS take any responsibility for any loss, damage, cost or expense incurred or arising by reason of any person using or relying on the data within this report, whether caused by reason of any error, omission or misrepresentation in the report of otherwise.”

Given Depuys track record, that disclaimer could raise some serious questions.

 

Well that explains the difference in revision rates. If this was same company that provided ASR data then we know it's all whacked data.

 

Well what was the explanation for great registry data with the ASR quickly followed by the recognition of many failures and a recall in the US?

 

Umm. Maybe this didn't get through to you. NJR is U.K. Depuy uses NJR data to promote even when they know data elsewhere shows flaws in products. Third party provided data has lots of ways to be manipulated. History repeating itself?
"The National Joint Registry produces this report through its contractor, Northgate Public Services (UK) Limited (NPS) using data collected, collated and provided by third parties. As a result, neither NJR or NPS take any responsibility for any loss, damage, cost or expense incurred or arising by reason of any person using or relying on the data within this report, whether caused by reason of any error, omission or misrepresentation in the report of otherwise.”

 

Huh?

 

Corporate playing dumb or you are to new to the industry.

 

Can't eat breakfast without seeing an Attune knee commercial anymore.

 

Maybe instead if watching tv you should go out and try and sell something!!